Anesth Analg 1988; 67:956-960
© 1988 International Anesthesia Research Society
Age Has No Effect on the Pharmacodynamics of Alfentanil
Harry J. M. Lemmens, MD,
James G. Bovill, MD, PhD, FFARCSI,
Pim J. Hennis, MD, PhD, and
Anton G. L. Burm, PhD
Department of Anesthesiology, University Hospital, Leiden, The Netherlands.
Abstract
Effects of age on the pharmacodynamics of alfentanil, as a supplement to nitrous oxide anesthesia, were studied in younger (31–52 years; n = 14) and older (56–86 years; n = 14) women undergoing curative surgery for primary breast cancer. Plasma alfentanil concentration-effect curves for perioperative stimuli and for the probability of needing naloxone at the end of the operation were fitted by logistic regression. Effects of age on the plasma concentration-effect relation of alfentanil could not be demonstrated. However, the dose requirement in the older patient group was significantly lower than in the younger patient group.
Key Words: ANALGESICS—alfentanil. ANESTHETICS—intravenous, alfentanil. PHARMACODYNAMICS—age, alfentanil. AGE FACTORSalfentanil pharmacokinetics.
|